Nycomed acquires distribution rights to product portfolio in Turkey
- Details
- Category: Nycomed

Novartis discontinues clinical trial of Tasigna®
- Details
- Category: Novartis

Boehringer Ingelheim maintains sales level/course set for the future: product pipeline well-filled
- Details
- Category: Boehringer Ingelheim

Pfizer and Medivation Announce Results from Phase 3 HORIZON Trial of Dimebon in Huntington Disease
- Details
- Category: Pfizer

Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
- Details
- Category: Bayer

Amgen Establishes Commercial Operations in Brazil
- Details
- Category: Amgen

Novartis sells global rights to Elidel®, a medicine to treat atopic dermatitis
- Details
- Category: Novartis

More Pharma News ...
- FDA approves orphan drug vandetanib
- Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
- Pfizer to Sell Capsugel to KKR
- Boehringer Ingelheim's lead hepatitis C compound moves into phase III
- GSK publishes payments for research, consulting and advising by US healthcare professionals
- Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010
- REACT study to evaluate impact of Daxas® (roflumilast) in patients receiving standard COPD treatment